CN103623099A - Sweet tea used for gout - Google Patents
Sweet tea used for gout Download PDFInfo
- Publication number
- CN103623099A CN103623099A CN201310615140.5A CN201310615140A CN103623099A CN 103623099 A CN103623099 A CN 103623099A CN 201310615140 A CN201310615140 A CN 201310615140A CN 103623099 A CN103623099 A CN 103623099A
- Authority
- CN
- China
- Prior art keywords
- extract
- gout
- sweet tea
- parts
- sweet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 13
- 235000009508 confectionery Nutrition 0.000 title claims abstract description 12
- 241001122767 Theaceae Species 0.000 title claims 3
- 239000012141 concentrate Substances 0.000 claims abstract description 5
- 241000345998 Calamus manan Species 0.000 claims description 5
- 235000012950 rattan cane Nutrition 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 244000269722 Thea sinensis Species 0.000 abstract description 9
- 208000024891 symptom Diseases 0.000 abstract description 8
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000146029 Lindera aggregata Species 0.000 abstract 1
- 240000009056 Saccharum arundinaceum Species 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 229940092665 tea leaf extract Drugs 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000036407 pain Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000004378 Glycyrrhizin Substances 0.000 description 3
- 244000228451 Stevia rebaudiana Species 0.000 description 3
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 3
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 3
- 229960004949 glycyrrhizic acid Drugs 0.000 description 3
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 3
- 235000019410 glycyrrhizin Nutrition 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 229940013618 stevioside Drugs 0.000 description 3
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 208000037157 Azotemia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010023203 Joint destruction Diseases 0.000 description 1
- 244000047734 Paederia foetida Species 0.000 description 1
- 235000019116 Paederia foetida Nutrition 0.000 description 1
- 241000219099 Parthenocissus quinquefolia Species 0.000 description 1
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 241001092459 Rubus Species 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000002279 cholagogic effect Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000009189 diving Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000037306 mature skin Effects 0.000 description 1
- NAFSTSRULRIERK-UHFFFAOYSA-M monosodium urate Chemical compound [Na+].N1C([O-])=NC(=O)C2=C1NC(=O)N2 NAFSTSRULRIERK-UHFFFAOYSA-M 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- -1 monoterpene glycosides Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 210000001171 synovial bursa Anatomy 0.000 description 1
- 208000009852 uremia Diseases 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses sweet tea used for gout. The sweet tea is prepared by mixing and processing the following materials in parts by weight: 5-6 parts of sweet cane extract, 1.5-2 parts of liquorice extract, 0.2-0.4 part of sweet tea leaf extract, 1.5-2 parts of lindera angustifolia concentrate, and 0.5-1.0 part of orange peel extract. The sweet tea disclosed by the invention can quickly control symptoms and can prevent progression of disease, is convenient to use, free from toxic and side effect, easily available in materials and low in treatment cost.
Description
Technical field
The present invention relates to Folium hydrangeae strigosae, specifically a kind of Folium hydrangeae strigosae for gout.
Background technology
Gout be fall ill in recent decades soar the fastest, insulting health, bright destruction joint, unbearable pain, deposition calculus, dark corrosion blood vessel, disturbs blood function, the more important thing is infringement kidney, the evil of diving renal function, causes renal failure, uremia.Also not effecting a radical cure at present good recipe, is generally anti symptom treatment.Conventional Western medicine is many, can control symptom, but side effect is large; Common Chinese medicine decoction, Chinese patent medicine are quite a few, and often slow curative effect, not remarkable, unstable.In recent years there are some to claim innovative product, " high-tech ", price extra-high-speed, the reducing swelling and alleviating pain time according to reports, need within three days, alleviate, within seven days, disappear.
Summary of the invention
The object of the invention is to provide a kind of Folium hydrangeae strigosae for gout, this Folium hydrangeae strigosae has no side effect, the symptom that swells and ache that can disappear fast, and can prevent PD, low price, natural plants.
The technical scheme that realizes the object of the invention is:
For a Folium hydrangeae strigosae for gout, by the following raw material of meter by weight ratio, through hybrid process granulation type Instant Drinks tea:
Sweet rattan extract 5-6
Radix Glycyrrhizae extract 1.5-2
Sweetleaf tea extract 0.2-0.4
JIANZHONGXIAO concentrate 1.5-2
Pericarpium Citri Reticulatae extract 0.5-1.0.
Described in formula:.
Sweet rattan (paederia scandens) extract: main component is fevervine monoterpene glycosides, is conventional pain relieving medical herbs among the people, tool analgesic antidotal, pathogenic wind expelling and blood circulation promoting, dehumidifying detumescence, dyspepsia and intestinal stasis relieving effect.Analgesia, significantly improves the threshold of pain, holds time for a long time in morphine, and without narcoticness, no dependence; In vitro tests has the effect of cortisone sample.Experiment report, this product is influential to hyperuricemia and uric acid sodium crystallization arthritis.Extracting method is prior art.
Radix Glycyrrhizae (glycyrrhiza uralensis) extract: main component is glycyrrhizin.Tool heat-clearing and toxic substances removing, relieving spasm to stop pain, invigorating the spleen and replenishing QI, expectorant cough-relieving, presses down acidolysis convulsion, the effect of hepatoprotective.Glycyrrhizin has renal cortex hormone and glucocorticoid sample antiinflammatory action.This product has Detoxication to multi-medicament and poisonous substance.Extracting method is prior art.
Sweetleaf tea (rubus suatrssimus) extract-stevioside: containing 24 kinds of nutritional labelings, be of high nutritive value, can delay sclerosis of blood vessels, anti-cardiovascular and cerebrovascular disease, promotes body constitution.Antiinflammatory, antiallergic.Stevioside sugariness low in calories is greater than sucrose 300----450 doubly.Extracting method is prior art.
JIANZHONGXIAO (radix ampelopsis) is feverfew tuber, refining concentrate.Tool heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, the effect of anti-inflammation.
Pericarpium Citri Reticulatae (citrus reticulate) is the extract of sweet Fructus Citri tangerinae dry mature skin, main component-Pericarpium Citri Reticulatae glycosides, and tool regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm, spasmolytic, hepatic cholagogic, the effect of antiinflammatory, antiallergic, extracting method is prior art.
Gout common sympton is local red and swollen heat pain, and Zhong Yi Debate card belongs to damp and hot characteristic.Its pathology be urate deposition in joint, synovial bursa, cartilage, subcutaneous tissue, the local aseptic inflammation reaction causing.Reusing sweet rattan removing damp and stopping pain is core, uses the glycyrrhizin of larger dose simultaneously, the same anti-inflammatory analgetic of performance 17-hydroxy-11-dehydrocorticosterone effect ， Association.Adapted JIANZHONGXIAO, urgees to help detumescence, anti-infection.The Main Function of stevioside is taste masking, improves Immunotherapy, and protection internal organs function is among the peoplely described as refreshing tea.Pericarpium Citri Reticulatae, spleen benefiting and stimulating the appetite, relaxing medical herbs together with Radix Glycyrrhizae may be to the uncomfortable reaction of a few peoples.Meanwhile, both alkalescence can also reduce blood uric acid, helps releasing symptom.
The using method of this Folium hydrangeae strigosae is: get 5-6 grams of Folium hydrangeae strigosae dissolved granulies at every turn and wash water open, add a cover 3---5 minute, warm frequency drink, light disease once a day, twice of serious symptom every day.Also can mix well local external application with vinegar or peak honey.
Advantage of the present invention is: energy quick control symptom, prevent PD, and easy to use, have no side effect, raw material is easy to get, and medical expense is low.
The specific embodiment
For a Folium hydrangeae strigosae for gout, by the following raw material of meter by weight ratio, through hybrid process granulation, made tea:
Sweet rattan extract 5
Radix Glycyrrhizae extract 1.5
Sweetleaf tea extract 0.2
JIANZHONGXIAO concentrate 1.5
Pericarpium Citri Reticulatae extract 0.5.
Application example:
Take the patient of this gout Folium hydrangeae strigosae, first day symptom all has and slows down; Pain disappearance situation sees attached list
Subordinate list
The effect analysis that 103 routine patient with gout are taken gout Folium hydrangeae strigosae
Claims (1)
1. for a Folium hydrangeae strigosae for gout, it is characterized in that: by the following raw material of meter by weight ratio, through mix homogeneously, be processed into granule Instant Drinks tea:
Sweet rattan extract 5-6
Radix Glycyrrhizae extract 1.5-2
Sweet tea extract 0.2-0.4
JIANZHONGXIAO concentrate 1.5-2
Pericarpium Citri Reticulatae extract 0.5-1.0.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310615140.5A CN103623099B (en) | 2013-11-28 | 2013-11-28 | A kind of Folium hydrangeae strigosae for gout |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310615140.5A CN103623099B (en) | 2013-11-28 | 2013-11-28 | A kind of Folium hydrangeae strigosae for gout |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103623099A true CN103623099A (en) | 2014-03-12 |
| CN103623099B CN103623099B (en) | 2016-06-22 |
Family
ID=50204783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310615140.5A Expired - Fee Related CN103623099B (en) | 2013-11-28 | 2013-11-28 | A kind of Folium hydrangeae strigosae for gout |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103623099B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104366636A (en) * | 2014-10-30 | 2015-02-25 | 袁丁 | Gynura procumbens compound preparation as well as preparation method and application thereof |
| CN107692228A (en) * | 2017-09-29 | 2018-02-16 | 武汉华士特工业生物技术开发有限公司 | A kind of Sweet tea composite extract and its preparation method and application |
| CN108713618A (en) * | 2018-05-03 | 2018-10-30 | 桂林漓峰医药用品有限责任公司 | A kind of deacidification Sweet tea |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099233A (en) * | 1994-08-01 | 1995-03-01 | 李振宏 | Preserved candied tea and its preparation |
| KR20020069129A (en) * | 2001-02-21 | 2002-08-29 | 정종문 | Functional powder for decomposing nicotine and manufacturing method of the same |
| CN1397322A (en) * | 2002-04-14 | 2003-02-19 | 郑子新 | Chinese medicine for treating gout and process for preparing its instant particles |
| CN1415344A (en) * | 2002-10-08 | 2003-05-07 | 丁心河 | Specific medicine of natural plants for curing sprain |
| US7201928B1 (en) * | 1999-09-21 | 2007-04-10 | Rutgers, The State University Of New Jersey | Extracts of orange peel for prevention and treatment of cancer |
| CN101874824A (en) * | 2009-05-01 | 2010-11-03 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Active extract containing trilobatin and application thereof |
-
2013
- 2013-11-28 CN CN201310615140.5A patent/CN103623099B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1099233A (en) * | 1994-08-01 | 1995-03-01 | 李振宏 | Preserved candied tea and its preparation |
| US7201928B1 (en) * | 1999-09-21 | 2007-04-10 | Rutgers, The State University Of New Jersey | Extracts of orange peel for prevention and treatment of cancer |
| KR20020069129A (en) * | 2001-02-21 | 2002-08-29 | 정종문 | Functional powder for decomposing nicotine and manufacturing method of the same |
| CN1397322A (en) * | 2002-04-14 | 2003-02-19 | 郑子新 | Chinese medicine for treating gout and process for preparing its instant particles |
| CN1415344A (en) * | 2002-10-08 | 2003-05-07 | 丁心河 | Specific medicine of natural plants for curing sprain |
| CN101874824A (en) * | 2009-05-01 | 2010-11-03 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Active extract containing trilobatin and application thereof |
Non-Patent Citations (3)
| Title |
|---|
| 冯春雷等: "《中药的性格》", 30 June 2011, article "菊三七", pages: 39 * |
| 周秋丽等: "《现代中药基础研究与临床》", 30 June 2012, article "鸡屎藤" * |
| 王廉等: "《实用饮料调制》", 31 August 2001, article "陈皮甘草茶", pages: 300 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104366636A (en) * | 2014-10-30 | 2015-02-25 | 袁丁 | Gynura procumbens compound preparation as well as preparation method and application thereof |
| CN104366636B (en) * | 2014-10-30 | 2016-07-20 | 袁丁 | A kind of Gynura procumbens (Lour.) Merr. compound formulation and preparation method and application |
| CN107692228A (en) * | 2017-09-29 | 2018-02-16 | 武汉华士特工业生物技术开发有限公司 | A kind of Sweet tea composite extract and its preparation method and application |
| CN108713618A (en) * | 2018-05-03 | 2018-10-30 | 桂林漓峰医药用品有限责任公司 | A kind of deacidification Sweet tea |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103623099B (en) | 2016-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN103623099A (en) | Sweet tea used for gout | |
| CN102626499B (en) | Traditional Chinese medicinal composition used as both food and medicine for treating porcine respiratory tract infection, and preparation method thereof | |
| CN103479947B (en) | The preparation method of control constipation medicine | |
| CN109078115A (en) | A kind of Chinese materia medica preparation and preparation method thereof for hemorrhage of digestive tract | |
| CN103223143B (en) | Traditional Chinese medicine composition for treating simple obesity, and preparation method and application thereof | |
| CN108524651B (en) | Traditional Chinese medicine composition for treating tracheitis | |
| CN105920364A (en) | Dendrobium officinale oral solution | |
| CN108079133A (en) | A kind of drug for treating dysmenorrhoea | |
| CN108066502A (en) | A kind of drug for treating dysmenorrhoea | |
| CN107029096B (en) | Traditional Chinese medicine compound preparation for treating leukemia caused by intermingled phlegm and blood stasis and preparation method thereof | |
| CN105233029A (en) | Chinese and western medicine compound preparation for premenstrual syndrome | |
| CN105148186A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN103611141B (en) | Traditional Chinese medicine for treating long-term cough | |
| CN104435832A (en) | Traditional Chinese drug composition for treating primary thrombocythemia | |
| CN105521326A (en) | Traditional Chinese medicine for treating hebra prurigo | |
| CN103536689A (en) | Pudendum cleaning bacteriostat liquid and preparation process thereof | |
| CN104208123A (en) | Folk prescription for treating hypertension | |
| CN104225512A (en) | Traditional Chinese medicine composition for treating colitis | |
| CN102973855A (en) | Chinese patent medicine granules used for treating cough | |
| CN103893301A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition for treating constipation | |
| CN103393748A (en) | Traditional Chinese medicine essence for treating gout and extraction technology thereof | |
| CN105641476A (en) | Medicine for treating rheumatoid arthritis and preparation method thereof | |
| CN106606604A (en) | Children acute bronchitis treating traditional Chinese medicine formula | |
| CN104225555A (en) | Traditional Chinese medicine formula for treating gastrointestinal hemorrhage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |